Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-07

Clinical Trial Update: Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia [NA]

View source ↗

Summary

A clinical trial is evaluating the DaRT device (Diffuse Alpha Radiation Therapy) for treating skin cancer, oral mucosal neoplasms, and superficial soft tissue n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DaRT (Diffuse Alpha Radiation Therapy) device (Diffuse Alpha Radiation Therapy device)

Snippet

Sponsor: Alpha Tau Medical LTD. | Conditions: Skin Cancer, Mucosal Neoplasm of Oral Cavity | NA | Status: RECRUITING